Company Profiles

driven by the PitchBook Platform

Sonitus Medical

2006 FOUNDED
OOB STATUS
51-200 EMPLOYEES
Liquidation LATEST DEAL TYPE
$86.3M TOTAL AMOUNT RAISED
Description

Developer of a non-invasive hearing device designed to treat single sided deafness and conductive hearing loss. The company's non-invasive hearing device is a removable and no-surgical prosthetic device that rely on the principle of bone conduction to transmit sound through teeth, enabling Otologists, ENTs and Audiologists to help their patients rejoin the conversation of life.

Ownership Status
Out of Business
Financing Status
Formerly VC-Backed
Primary Industry
Therapeutic Devices
Primary Office
1900 Alameda De Las Pulgas
Suite 200
San Mateo, CA 94403
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sonitus Medical’s full profile, request a free trial.

Sonitus Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Liquidation 15-Jan-2015 $86.3M Completed Bankruptcy: Liquidation
10. Later Stage VC (Series D1) 28-Apr-2014 000.00 000.00 00000 Completed Generating Revenue
9. Debt - General 18-Sep-2013 0000 000.00 Completed Generating Revenue
8. Later Stage VC (Series D) 23-May-2012 0000 000.00 000.00 Completed Generating Revenue
7. Later Stage VC (Series C) 08-Apr-2011 0000 000.00 000.00 Completed Startup
6. Early Stage VC 26-May-2009 000.00 Completed Startup
5. Early Stage VC 01-Apr-2009 00000 000.00 Completed Startup
4. Early Stage VC 30-Jan-2009 000.00 000.00 000.00 Completed Startup
3. Early Stage VC 19-Oct-2007 0000 00.000 Completed Startup
2. Early Stage VC (Series A2) 31-Jul-2007 $355k $5.14M Completed Startup
1. Early Stage VC 08-Sep-2006 $4.79M $4.79M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Sonitus Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series D1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.00
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A2 6,759,000 $0.000100 $0.04 $0.51 $0.51 1x $0.51 4.28%
Series A1 5,000,000 $0.000100 $0.02 $0.3 $0.3 1x $0.3 3.17%
To view this company’s complete Cap Table request access »

Sonitus Medical Executive Team (1)

Name Title Board
Seat
Contact
Info
Kurt Carlson Ph.D Vice President, Legal Affairs and General Counsel